| Literature DB >> 30782123 |
Hang Fan1, Ke Li1,2, Fan Yao1, Liwei Sun3, Yujun Liu4.
Abstract
BACKGROUND: There exist differences in morphological traits and phytochemical compositions between field- and mountain-cultivated Panax ginseng (FCG and MCG), which might be attributed to variations of terpenoids metabolism adapting to different growth conditions. The present work aims to uncover these variations. <br> RESULTS: Among 26,648 differentially expressed genes, 496 genes distributed in seven dominant terpenoids pathways were identified. Diterpenoids and triterpenoids biosynthesis genes were significantly higher-expressed in FCG root. Conversely, biosynthesis of carotenoids was significantly more active in MCG root. Additionally, terpenoids backbones, monoterpenoids, sesquiterpenoids, and terpenoid-quinones biosyntheses were neither obviously inclined. Our determination also revealed that there were more gibberellins and steroids accumulated in FCG root which might be responsible for its quick vegetative growth, and enriched abscisic acid and germacrenes as well as protopanaxatriol-type ginsenosides might be major causes of enhanced stress-resistance in MCG root. <br> CONCLUSIONS: The study firstly provided an overview of terpenoids metabolism in roots of FCG and MCG in elucidating the underlying mechanisms for their different morphological appearances and phytochemical compositions.Entities:
Keywords: Field-cultivated ginseng; Ginsenosides; Mountain-cultivated ginseng; Terpenoid phytohormones; Terpenoids biosynthesis genes; Transcriptome analysis
Mesh:
Substances:
Year: 2019 PMID: 30782123 PMCID: PMC6381674 DOI: 10.1186/s12870-019-1682-5
Source DB: PubMed Journal: BMC Plant Biol ISSN: 1471-2229 Impact factor: 4.215
Fig. 1Typical morphologies of field- and mountain-cultivated Panax ginseng plants. Left, a 4-year-old field-cultivated ginseng; right, an 8-year-old mountain-cultivated ginseng
Fig. 2GO classifications of reference and new genes. The results are summarized in three main GO categories: biological process, cellular component, and molecular function. BP, biological process; CC, cellular component; MF, molecular function
Fig. 3Histogram of COG functional classification. The X axes at the top and bottom present numbers of new and reference genes annotated by COG analysis, respectively. The COG functional classification from top to bottom is sorted from large to small by numbers of reference genes
Fig. 4Biosyntheses of various terpenoids in the two types of ginseng root. Acronyms of the enzymes catalyzing corresponding biochemical reactions are written in green and red as indicated by the coloration scale presented to the upright corner of this figure, which were encoded by genes higher-expressed in field- and mountain-cultivated ginseng (FCG and MCG) roots, respectively. a Terpenoid backbone biosynthesis: ACT, acetyl-CoA C-acetyltransferase; HMGS, hydroxymethylglutaryl-CoA synthase; HMGCR, hydroxymethylglutaryl-CoA reductase; mvaK1, mevalonate kinase; mvaK2, phosphomevalonate kinase; mvaD, diphosphomevalonate decarboxylase; DXS, 1-deoxy-D-xylulose-5-phosphate synthase; DXR, 1-deoxy-D-xylulose-5-phosphate reductoisomerase; ispD, 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase; ispG, (E)-4-hydroxy-3-methylbut-2-enyl-diphosphate synthase; ispH, 4-hydroxy-3-methylbut-2-en-1-yl diphosphate reductase; IDI, isopentenyl-diphosphate delta-isomerase; GGPS, geranylgeranyl diphosphate synthase; FDPS, farnesyl diphosphate synthase; FNTA/B, alpha/beta-protein farnesyltransferase; PCYOX1, prenylcysteine oxidase; FLDH, NAD+ −dependent farnesol dehydrogenase; FOLK, farnesol kinase. b Diterpenoids biosynthesis: ent-KS, ent-kaurene synthase; KAO, ent-kaurenoic acid hydroxylase; GA20ox, gibberellin 20-oxidase; GA3ox1, gibberellin 3-beta-dioxygenase; GA2ox, gibberellin 2-oxidase. c Carotenoids biosynthesis: crtB, 15-cis-phytoene/all-trans-phytoene synthase; PD, 15-cis-phytoene desaturase; ZDS, zeta-carotene desaturase; crtISO, prolycopene isomerase; lcyB, lycopene beta-cyclase; LUT5, beta-ring hydroxylase; CCD7, 9-cis-beta-carotene 9′,10′-cleaving dioxygenase; CCD8, carlactone synthase; DWARF27, beta-carotene isomerase; ZEP, zeaxanthin epoxidase; VDE, violaxanthin de-epoxidase; CCS1, capsanthin/capsorubin synthase; NCED, 9-cis-epoxycarotenoid dioxygenase; ABA2, xanthoxin dehydrogenase; AAO3, abscisic-aldehyde oxidase; ABAH, (+)-abscisic acid 8′-hydroxylase. d Triterpenoids biosynthesis: FDFT1, farnesyl-diphosphate farnesyltransferase; SQLE, squalene monooxygenase; CAS, cycloartenol synthase; DS, dammarenediol-II synthase; β-AS, beta-amyrin synthase; PDS, protopanaxadiol synthase; PTS, protopanaxatriol synthase; SMT1, sterol 24-C-methyltransferase; SMO1, 4,4-dimethyl-9beta,19-cyclopropylsterol-4alpha-methyl oxidase; CPI1, cycloeucalenol cycloisomerase; CYP51, sterol 14-demethylase; FK, delta14-sterol reductase; EBP, cholestenol Delta-isomerase; SMO2, 4-alpha-methyl-delta7-sterol-4alpha-methyl oxidase; ERG3, delta 7-sterol-5-desaturase; SMT2, 24-methylenesterol C-methyltransferase; DHCR7, 7-dehydrocholesterol reductase; DHCR24, delta24-sterol reductase; CYP710A, steroid 22-desaturase; CYP90B1, steroid 22-alpha-hydroxylase; CYP724B1, cytochrome P450 family 724 subfamily B polypeptide 1; CYP90A1, cytochrome P450 family 90 subfamily A polypeptide 1; CYP90D1, cytochrome P450 family 90 subfamily D1; CYP85A2, cytochrome P450 family 85 subfamily A2; CYP734A1, PHYB activation tagged suppressor 1. e Monoterpenoids biosynthesis: (−)-α-TS, (−)-alpha-terpineol synthase; (+)-ND, (+)-neomenthol dehydrogenase; menA, 1,4-dihydroxy-2-naphthoate octaprenyltransferase. f Sesquiterpenoids biosynthesis: GERD, (−)-germacrene D synthase; CYP71D55, premnaspirodiene oxygenase; TPS1, valencene/7-epi-alpha-selinene synthase. g terpenoid-quinone biosynthesis: menA, 1,4-dihydroxy-2-naphthoate octaprenyltransferase; ubiE, demethylmenaquinone methyltransferase; wrbA, NAD(P)H dehydrogenase; HPT, homogentisate phytyltransferase; VTE1, tocopherol cyclase; TOMT, tocopherol O-methyltransferase; HST, homogentisate solanesyltransferase; VTE3, 2-methyl-6-phytyl-1,4-hydroquinone methyltransferase
Fig. 5Validations of transcriptome analyses of the two types of ginseng root. a Expression levels of nine randomly selected differentially expressed genes (DEGs) determined by qRT-PCR. Gene expressions calculated by fold change of 2 – (ΔCtMCG-ΔCtFCG) below (the left side six columns) and above (the right side three columns) 1.0 indicated those genes being significantly higher-expressed in field- and mountain-cultivated ginseng (FCG and MCG) roots, respectively. FDPS, farnesyl diphosphate synthase; HMGCR, hydroxymethylglutaryl-CoA reductase; SQLE, squalene monooxygenase; GA20ox, gibberellin 20-oxidase; GA3ox1, gibberellin 3-beta-dioxygenase; GA2ox, gibberellin 2-oxidase; VTE3, MPBQ/MSBQ methyltransferase; ABA2, xanthoxin dehydrogenase; (+)-ND, (+)-neomenthol dehydrogenase. b Contents of ABA and GA in the two types of ginseng root. Columns in green and yellow represent FCG and MCG roots, respectively. Contents of ABA and GA are expressed as ng/g f.w. (n = 3). “**” indicates extremely significant difference (P < 0.01)
Contents of ginsenosides in roots of field- and mountain-cultivated ginsengs
| Ginsenosides | MCG | FCG | |
|---|---|---|---|
| PPD-type ginsenosides | Rc | 31.600 ± 1.242 | 34.553 ± 1.098* |
| Rb2 | 26.693 ± 1.407 | 39.323 ± 0.673** | |
| Rb3 | 8.060 ± 0.465 | 10.606 ± 0.159** | |
| Rb1 | 37.093 ± 4.422 | 64.100 ± 5.982** | |
| Rd | 17.925 ± 2.887 | 21.427 ± 0.790 | |
| Rh2 | 13.188 ± 0.106 | 19.071 ± 0.613** | |
| total | 134.558 ± 10.530 | 189.081 ± 9.315** | |
| PPT-type ginsenosides | Rg1 | 72.615 ± 1.711** | 55.210 ± 0.872 |
| Re | 49.430 ± 3.647 | 60.201 ± 0.790** | |
| Rf | 21.462 ± 0.332 | 26.092 ± 1.375** | |
| Rg2 | 12.340 ± 1.348 | 13.588 ± 1.611 | |
| F1 | 6.750 ± 1.518 | 5.849 ± 0.652 | |
| total | 162.596 ± 8.556 | 160.941 ± 5.300 | |
Contents of ginsenosides are expressed as mg/g f.w. (n = 3). PPD-type ginsenosides, protopanaxadiol-type ginsenosides; PPT-type ginsenosides, protopanaxatriol-type ginsenosides. “*” and “**” indicated a significant (P < 0.05 and > 0.01) and an extremely significant (P < 0.05 and > 0.01) differences, respectively
Comparison of key terpenoids detected by GC-MS
| CAS | Compounds | Name | Ratio of contenta | |
|---|---|---|---|---|
| Monoterpenoids | 61142–32-3 | C10H18 | 1,3-dimethyl-2-(1-methylethyl)-cyclopentene | Fb |
| 99-82-1 | C10H20 | p-menthane | 1.279 | |
| Sesquiterpenoids | 25246–27-9 | C15H24 | alloaromadendrene | Mb |
| 515-13-9 | C15H24 | beta-elemene | M | |
| 17334–55-3 | C15H24 | calarene | 2.454 | |
| 56633–28-4 | C15H24 | alpha-panasinsene | M | |
| 56684–96-9 | C15H24 | beta-neoclovene | M | |
| 23986–74-5 | C15H24 | germacrene D | M | |
| 489–39-4 | C15H24 | aromandendrene | M | |
| 21747–46-6 | C15H24 | ledene | M | |
| 29873–99-2 | C15H24 | gamma-elemene | 1.688 | |
| 23445–02-5 | C15H26O | cubebol | M | |
| Diterpenoids | 1686-63-1 | C20H30O | isopimaral | 0.473 |
| 1686-54-0 | C21H32O2 | 1-phenanthrenecarboxylic acid | M | |
| Triterpenoids | 57–87-4 | C28H44O | ergosterol | 0.625 |
| 7144-08-3 | C28H45ClO2 | cholesterol chloroformate | 0.903 | |
| 67–96-9 | C28H46O | dihydrotachysterol | 0.608 | |
| 51014–22-3 | C28H46O | 4-campestene-3-one | 0.516 | |
| 2034-72-2 | C29H46O | stigmasta-3,5-dien-7-one | 0.236 | |
| 79897–80-6 | C29H48 | stigmasta-3,5-diene | M | |
| 83–48-7 | C29H48O | stigmasta-5,22-dien-3-ol | 0.682 | |
| 83–47-6 | C29H50O | gamma-sitosterol | 0.677 | |
| 638–95-9 | C30H50O | alpha-amyrin | 0.313 | |
| 473–98-3 | C30H50O2 | lup-20 (29)-ene-3,28-diol | 0.726 | |
| 4651-48-3 | C31H50O2 | stigmasta-5,22-dien-3-ol, acetate | 0.889 | |
| 1449-09-8 | C31H52O | 24-methylenecycloartano | 0.396 | |
| 915–05-9 | C31H52O2 | stigmast-5-en-3-ol, acetate | 0.931 | |
| 1617-68-1 | C32H52O2 | lupeol acetate | F | |
| 1259-10-5 | C32H52O2 | cycloartenol acetate | 0.85 | |
| Terpenoid-quinone | 59–02-9 | C29H50O2 | tocopherol | 0.514 |
| 29790–47-4 | C50H70O2 | 1,4-naphthoquinone | 1.536 | |
| Others | 25061–77-2 | C14H12O2 | 9,10-phenanthrenediol | F |
| 72800–72-7 | C17H24O2 | panaxydol | 0.483 |
aRatio of content was calculated based on ion peaks area of MCG root to that of FCG root. The ratio numbers colored in green and red represented the compound was higher-accumulated in FCG and MCG roots, respectively
bLetters ‘F’ and ‘M’ indicate those compounds detected only in FCG and MCG, respectively
Fig. 6Distribution of differentially expressed TFs in 33 TF families. Y axis represented the numbers of TFs in each family. The columns in green and red meant the TFs were significantly higher-expressed in FCG and MCG, respectively. At the X axis, families of the TFs from left to right are sorted from large to small by numbers of them higher-expressed in FCG root
Fig. 7A conceptual model for difference in terpenoids biosyntheses between FCG and MCG. The terpenoids in green and red box indicate an active biosynthesis in FCG and MCG, respectively